It’s a new era for Alzheimer’s treatment, care and support, but work remains. Help us address these challenges. Urge Congress to act.
Significant progress in Alzheimer’s and dementia research and the recent Food and Drug Administration (FDA) approval of treatments to slow progression of early Alzheimer's have provided great hope. As we enter a new era of Alzheimer's treatment, care and support, work still remains to address the unique health care challenges of the disease.